Checkmate Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (Checkmate), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the BTIG Virtual Biotechnology Conference from 3:30-3:55pm ET on Monday, August 9, 2021.
- Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (Checkmate), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the BTIG Virtual Biotechnology Conference from 3:30-3:55pm ET on Monday, August 9, 2021.
- Checkmate will also host 1x1 investor meetings during the conference.
- Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer.
- The information that Checkmate Pharmaceuticals posts on these channels and websites could be deemed to be material information.